瑞普生物：公司目前无尼帕病毒相关的针对性疫苗、药品

Core Viewpoint - The company, Reap Bio, announced on January 29 that it currently does not have any targeted vaccines or drugs related to the Nipah virus and will continue to monitor the virus dynamics to assess research and development opportunities [1]. Company Summary - Reap Bio is actively monitoring the Nipah virus situation and is open to evaluating potential R&D opportunities in response to the virus [1].